New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
June 17, 2014
04:55 EDTMRGE, MRGE, KND, KND, IMMU, IMMU, COO, COO, CVS, CVS, ARNA, ARNA, GMED, GMED, ISIS, ISIS, Q, Q, STML, STML, BDSI, BDSI, DEPO, DEPOWells Fargo to hold a conference
2014 Healthcare Conference to be held in Boston on June 17-18.
News For MRGE;BDSI;STML;Q;ISIS;GMED;ARNA;CVS;COO;IMMU;KND;DEPO From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
April 15, 2015
10:00 EDTGMEDOn The Fly: Analyst Initiation Summary
Subscribe for More Information
09:54 EDTKNDWells positive on HealthSouth, Kindred after ''doc fix'' bill
Subscribe for More Information
April 14, 2015
16:16 EDTGMEDGlobus Medical initiated with an Outperform at Wells Fargo
Subscribe for More Information
14:42 EDTGMEDSmall spine names have positive read through from J&J results, says Wells Fargo
Subscribe for More Information
April 13, 2015
08:09 EDTDEPODepomed enters into settlement agreement with Actavis
Subscribe for More Information
07:31 EDTMRGEHealthcare Information & Management Systems Society to hold a conference
HIMSS 2015 is being held in Chicago on April 12-16.
07:29 EDTMRGELeerink to hold booth tours at HIMSS
Subscribe for More Information
April 10, 2015
19:43 EDTISISIsis Pharmaceuticals management to meet with JPMorgan
Subscribe for More Information
08:06 EDTARNAEisai and Arena Pharmaceuticals complete trials of formulation of lorcaserin
Subscribe for More Information
April 8, 2015
16:11 EDTISISRegulus files to sell 3.3M shares for Isis Pharmaceuticals
Subscribe for More Information
10:01 EDTBDSIOn The Fly: Analyst Initiation Summary
Subscribe for More Information
April 7, 2015
19:10 EDTBDSIOn The Fly: After Hours Movers
Subscribe for More Information
16:10 EDTBDSIBioDelivery Sciences initiated with a Buy at Cantor
Subscribe for More Information
09:23 EDTARNAOn The Fly: Pre-market Movers
Subscribe for More Information
08:03 EDTARNAArena Pharmaceuticals receives additional patent for Belviq from USPTO
Arena Pharmaceuticals and Eisai announced that the US Patent and Trademark Office granted Arena US Patent No. 8,999,970, which describes a method for selecting appropriate patients based on renal function for BELVIQ, a serotonin 2C receptor agonist approved for weight management. In addition to this method-of-treatment patent, composition of matter patents for BELVIQ are issued in major jurisdictions globally that, in most cases, are capable of continuing into 2023. Arena has filed applications for patent term extension on patents directed to composition of matter in the United States, which, if granted, would extend the composition of matter patent term for BELVIQ into 2026 or potentially 2027.
06:08 EDTCVSNew York REIT announces 22,00 square foot lease with CVS at 1440 Broadway
New York REIT (NYRT) announced that is has completed a long-term lease totaling approximately 22,000 square feet with CVS/pharmacy (CVS) at 1440 Broadway. The deal marks the first step in NYRT's overall retail repositioning strategy at 1440 Broadway, with remaining value-add opportunities to mark existing below-market tenant rents to market and to re-configure a portion of the basement into valuable, lower-level selling space with double ceiling-heights.
April 6, 2015
14:34 EDTDEPODepomed price target raised to $30 from $27 at Roth Capital
Subscribe for More Information
11:11 EDTBDSIOptions with decreasing implied volatility
Options with decreasing implied volatility: BDSI CONN HLSS CTRX DANG ARCP KMX MAC
08:32 EDTIMMUImmunomedics to provide update on sacituzumab govitecan at AACR meeting
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use